Core Viewpoint - The company has approved the continued use of raised funds to purchase financial products or structured deposits, aiming to enhance fund utilization efficiency while ensuring that it does not affect the construction of investment projects or the use of raised funds [2][14]. Summary by Sections Fundraising Overview - The company raised a total of 1,315,319,983.02 RMB through a non-public offering of 115,076,114 shares at a price of 11.43 RMB per share, with a net amount of 1,303,670,100.75 RMB after deducting various fees [2][4]. Fund Management - The company has established a special account for the management and storage of raised funds, ensuring that all funds are deposited in a board-approved special account and are subject to regulatory agreements with the sponsoring institution and the commercial bank [3]. Investment Projects - The company has adjusted its investment projects, reallocating funds from the "Health Industry Expansion Project" to invest 45,800.58 million RMB in the "Traditional Chinese Medicine Production Base Construction Project" [5]. Cash Management - The company plans to use up to 850 million RMB of idle raised funds for purchasing safe, liquid financial products or structured deposits with a capital preservation commitment, with the authority to make investment decisions granted to the chairman or CFO [10][14]. Risk Control Measures - The company will select financial products from issuers that can provide capital preservation guarantees, ensuring high safety and liquidity, and will not affect the normal operation of the investment projects [15][17]. Approval Process - The decision to continue using idle raised funds for financial products was approved by the board's audit committee and the board of directors, confirming compliance with relevant regulations and ensuring that it aligns with the interests of the company and its shareholders [13][18].

Group 1 - The company completed the cancellation of its fundraising special account as part of its financial management strategy [4] - The company raised a total of RMB 383,714,880.00 through a non-public offering of 88,008,000 shares at RMB 4.36 per share, with a net amount of RMB 376,615,860.47 after deducting fees [2][3] - The company established a special account for the management of the raised funds, in compliance with relevant laws and regulations [2][3] Group 2 - The company approved the conclusion of several fundraising projects and decided to permanently supplement its working capital with the remaining funds [3][4] - The special account for the "Beihai Chengde Nickel Industry 132+180 Sintering Denitrification EPC Project" has been closed, and the remaining funds were transferred to the company's own account [4] - The agreements related to the special account management with the sponsor and banks have been terminated following the account closure [4]

Core Points - The company held its 35th temporary board meeting on November 21, 2025, where several key resolutions were passed, including increasing registered capital, changing the company name, and revising the articles of association [1][56] - The company plans to change its name from "State Power Investment Group Yuanda Environmental Protection Co., Ltd." to "State Power Investment Group Hydropower Co., Ltd." to better reflect its core business focus following a major asset restructuring [56] - The registered capital will increase from RMB 780,816,890 to RMB 4,380,206,201 through the issuance of 3,599,389,311 shares to specific investors [57] Summary by Category Capital Increase and Name Change - The board unanimously approved the proposal to increase registered capital and change the company name, with all 11 votes in favor [1][56] - The new registered capital will be RMB 4,380,206,201, reflecting a significant increase to support the company's strategic transformation [57] Related Party Transactions - The board approved adjustments to the expected daily related party transaction limits for 2025 and 2026, with 6 votes in favor and 5 abstentions from related directors [3][41] - The adjustments are deemed necessary for normal business operations and are expected to be fair and reasonable, not harming the interests of minority shareholders [40][41] Audit Firm Appointment - The company renewed its appointment of Crowe Horwath as the financial audit firm for the fiscal year 2025, with unanimous approval from the board [5][21] - The audit fee for 2025 is set at RMB 2,681,000, reflecting an increase due to the expanded scope of the audit following the acquisition of new assets [18] Shareholder Meeting - A temporary shareholder meeting is scheduled for December 12, 2025, to discuss the approved resolutions, including the capital increase and name change [24][25] - The meeting will allow for both on-site and online voting, ensuring broader participation from shareholders [25][26]

登录新浪财经APP 搜索【信披】查看更多考评等级 证券代码：603717 证券简称：天域生物 公告编号：2025-106 天域生物科技股份有限公司关于 变更保荐机构后重新签订募集资金 三方监管协议的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大遗漏，并对其内容 的真实性、准确性和完整性承担法律责任。 天域生物科技股份有限公司（以下简称"公司"）于2025年10月25日披露了《关于变更保荐机构及保荐代 表人的公告》（公告编号：2025-099），公司因聘请国海证券股份有限公司（以下简称"国海证券"）担 任公司2025年度向特定对象发行A股股票事项的保荐机构，原保荐机构中德证券有限责任公司尚未完成 的持续督导工作由国海证券承接。为规范募集资金管理，保护投资者利益，根据《上市公司募集资金监 管规则》《上海证券交易所股票上市规则》《上海证券交易所上市公司自律监管指引第1号一一规范运 作》等有关法律、法规和规范性文件的规定，公司于近日与国海证券、南洋商业银行（中国）有限公司 上海分行重新签订了《募集资金专户存储三方监管协议》。现将有关情况公告如下： 一、募集资金基本情况 经中国证券监督 ...

Group 1 - The company held its 22nd meeting of the 6th Board of Directors on November 20, 2025, via telecommunication, with all 8 directors present, meeting the legal quorum requirements [2][3][6] - The Board approved the proposal to conclude the fundraising project for issuing convertible bonds and to permanently supplement the remaining funds of 223.2049 million yuan into working capital for daily operations and business development [3][4][39] - The proposal to convene the second extraordinary general meeting of shareholders in 2025 was also approved, scheduled for December 10, 2025 [9][10][11] Group 2 - The company plans to transfer 90% of its wholly-owned subsidiary, Suzhou Jinlaike Precision Machinery Co., Ltd., to Suzhou Chuangyuan Resource Recycling Co., Ltd., with an intended total equity value of 235 million yuan [44][46] - This transaction does not constitute a related party transaction or a major asset restructuring, and the signed letter of intent is preliminary, subject to further due diligence and negotiations [45][46][66] - The decision to sell the subsidiary aims to optimize the company's asset structure and resource allocation, enhancing operational efficiency and reducing management costs [65]

Fundraising Overview - The company raised a total of RMB 1,759,999,998.24 through the issuance of 444,444,444 shares at a price of RMB 3.96 per share, with a net amount of RMB 1,727,912,422.10 after deducting issuance costs [1] Fund Management and Storage - The company established a fundraising management system to ensure effective use of raised funds, which are stored in a dedicated account [2] - A tripartite supervision agreement was signed with the sponsor and the bank to oversee the use of the funds [2] Changes in Fund Account - On July 3, 2023, the company approved a proposal to change the dedicated fundraising account from Industrial Bank to Bank of China [3] - A new tripartite supervision agreement was signed with the new bank to ensure compliance [3] Account Closure - The fundraising account was closed after the funds were fully utilized, and the corresponding supervision agreement was terminated [3][4]

上海雅仕投资发展股份有限公司 第四届董事会第十三次会议决议公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大遗漏，并对其内容 的真实性、准确性和完整性承担法律责任。 二、董事会会议审议情况 本次董事会会议审议并通过了以下议案： (一)审议通过《关于增加募投项目实施主体并使用部分募集资金向新增实施主体提供借款以实施募投项 目议案》 登录新浪财经APP 搜索【信披】查看更多考评等级 证券代码：603329 证券简称：上海雅仕 公告编号：2025-074 一、董事会会议召开情况 上海雅仕投资发展股份有限公司（以下简称"公司"）第四届董事会第十三次会议于2025年11月19日在公 司会议室以现场结合通讯表决方式召开，会议通知及相关资料已于2025年11月14日以电子邮件方式发 出。本次会议应出席会议的董事9名，实际出席会议的董事9名，其中现场参会董事4名，以通讯表决方 式参会董事5名，部分高级管理人员列席会议，本次会议由董事长刘忠义先生主持。会议参与表决人数 及召集、召开程序符合《公司法》和《公司章程》的有关规定，所作决议合法有效。 同意公司新增全资子公司湖北雅仕实业控股有限公司作为募投 ...

登录新浪财经APP 搜索【信披】查看更多考评等级 证券代码：603329 证券简称：上海雅仕 公告编号：2025-076 上海雅仕投资发展股份有限公司 关于使用募集资金置换已支付发行 费用的自筹资金的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大遗漏，并对其内容 的真实性、准确性和完整性承担法律责任。 上海雅仕投资发展股份有限公司（以下简称"公司""上海雅仕"）于2025年11月19日召开第四届董事会第 十三次会议，审议通过了《关于使用募集资金置换已支付发行费用的自筹资金的议案》，同意公司使用 募集资金置换已支付发行费用的自筹资金，置换金额为人民币752,830.19元（不含税），本次募集资金 置换时间距募集资金到账日未超过6个月，符合相关法律法规的规定。现将有关情况公告如下： 一、募集资金基本情况 经中国证券监督管理委员会《关于同意上海雅仕投资发展股份有限公司向特定对象发行股票注册的批 复》（证监许可〔2025〕1825号）同意，公司本次向特定对象发行人民币普通股（A股）43,668,122 股，发行价格6.87元/股，募集资金总额为299,999,998.14元，扣除不含 ...

登录新浪财经APP 搜索【信披】查看更多考评等级 ■ 盛美半导体设备（上海）股份有限公司 关于使用自有资金方式支付募投项目所需资金 并以募集资金等额置换的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大遗漏，并对其内容 的真实性、准确性和完整性依法承担法律责任。 盛美半导体设备（上海）股份有限公司（以下简称"公司"、"盛美上海"）于2025年11月17日召开第三届 董事会第一次会议，审议通过了《关于使用自有资金方式支付募投项目所需资金并以募集资金等额置换 的议案》。为提升公司运营管理效率，同意公司在募集资金投资项目（以下简称"募投项目"）实施期间 使用自有资金方式支付募投项目所需部分资金，后续以募集资金等额置换，从募集资金专户划转资金至 公司非募集资金账户，该部分置换资金视同募投项目使用资金。保荐机构国泰海通证券股份有限公司 （以下简称"保荐机构"）对本事项出具了明确的核查意见，现将具体情况公告如下： 一、募集资金的基本情况 根据中国证券监督管理委员会核发的《关于同意盛美半导体设备（上海）股份有限公司向特定对象发行 股票注册的批复》（证监许可[2025]1338号），公司于20 ...

Core Points - The company held its 12th meeting of the 10th Board of Directors on November 18, 2025, where several key resolutions were passed [1][2][3][4]. Group 1: Board Resolutions - The company approved the nomination of Hua Guanglin as a candidate for a non-independent director, pending shareholder approval [2][5][87]. - The company accepted the resignation of Zhao Shukun as General Manager due to work adjustments and appointed Hua Guanglin as the new General Manager [6][84]. - The company resolved to amend its Articles of Association to align with new legal requirements and improve governance [9][37]. - The company decided to revise the rules for shareholder meetings to clarify responsibilities and ensure legal compliance [12][37]. - The company approved the revision of the rules for board meetings to enhance decision-making efficiency [15][37]. - The company resolved to abolish the Supervisory Board, transferring its responsibilities to the Audit and Risk Management Committee [18][37]. - The company agreed to use 120 million yuan of idle raised funds temporarily to supplement working capital, with a usage period not exceeding six months [21][67][76]. - The company scheduled its second extraordinary general meeting for 2025 on December 4, 2025 [24][41]. Group 2: Meeting Details - The board meeting was conducted in compliance with the Company Law and the company's Articles of Association, with all members present [1][4]. - The resolutions passed during the meeting will be submitted for approval at the upcoming shareholders' meeting [5][11][14][20]. Group 3: Management Changes - Hua Guanglin, the newly appointed General Manager, has a strong background in engineering and management, having held various positions within the company [26][86][89].